24 May 2013
Keywords: sirna, lilly, enter, rnai, collaboration, therapeutics, entered
Article | 02 February 2004
Sirna Therapeutics has entered into a collaboration with drug major Eli Lilly to develop novel RNA-interference therapeutics. During the 18-month ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.